Stephen Ma
Director of Finance/CFO at SCILEX HOLDING COMPANY
Net worth: 17 431 $ as of 30/05/2024
Stephen Ma active positions
Companies | Position | Start | End |
---|---|---|---|
SCILEX HOLDING COMPANY | Investor Relations Contact | 31/12/2021 | - |
Director of Finance/CFO | 21/09/2023 | - | |
Public Communications Contact | 31/12/2021 | - | |
Corporate Secretary | 05/03/2024 | - | |
Comptroller/Controller/Auditor | 31/10/2022 | - |
Career history of Stephen Ma
Former positions of Stephen Ma
Companies | Position | Start | End |
---|---|---|---|
Anwita Biosciences, Inc.
Anwita Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Anwita Biosciences, Inc. is a clinical stage biopharmaceutical company located in the US. Anwita's lead product, exenokine-21, has been accepted by China NMPA and the US FDA to initiate clinical studies. The American company specializes in the discovery and development of optimized immunotherapeutics for cancer and autoimmune diseases. Anwita's core technology integrates structure-guided accukine cytokine evolution and accubody discovery of full spectrum nanobodies and antibodies, enabling the development of fully optimized cytokine fusions with superior therapeutic potential, favorable safety profile, and great development ability. The private company's unique product portfolio includes half-live extended exenokines, immune cell- or tumor cell-targeting mableukines, and bi-functional duoleukins. The company is also developing other cytokine-based therapeutics and antibody drug conjugates for the potential treatment of various cancers. | Chief Operating Officer | 31/07/2019 | 31/12/2021 |
Director of Finance/CFO | 31/07/2019 | 31/12/2021 |
Training of Stephen Ma
San Jose State University | Graduate Degree |
Statistics
International
United States | 4 |
Operational
Director of Finance/CFO | 2 |
Comptroller/Controller/Auditor | 1 |
Investor Relations Contact | 1 |
Sectoral
Health Technology | 3 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
SCILEX HOLDING COMPANY | Health Technology |
Private companies | 1 |
---|---|
Anwita Biosciences, Inc.
Anwita Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Anwita Biosciences, Inc. is a clinical stage biopharmaceutical company located in the US. Anwita's lead product, exenokine-21, has been accepted by China NMPA and the US FDA to initiate clinical studies. The American company specializes in the discovery and development of optimized immunotherapeutics for cancer and autoimmune diseases. Anwita's core technology integrates structure-guided accukine cytokine evolution and accubody discovery of full spectrum nanobodies and antibodies, enabling the development of fully optimized cytokine fusions with superior therapeutic potential, favorable safety profile, and great development ability. The private company's unique product portfolio includes half-live extended exenokines, immune cell- or tumor cell-targeting mableukines, and bi-functional duoleukins. The company is also developing other cytokine-based therapeutics and antibody drug conjugates for the potential treatment of various cancers. | Health Technology |
- Stock Market
- Insiders
- Stephen Ma
- Experience